Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.10M | -2.06M | -2.66M | -2.74M | -490.20K |
| Total Depreciation and Amortization | 70.40K | 68.90K | 66.00K | 67.90K | 67.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.57M | -2.52M | 3.16M | 3.25M | -1.17M |
| Change in Net Operating Assets | 1.63M | 1.59M | -- | -- | -1.85M |
| Cash from Operations | -2.98M | -2.92M | 566.60K | 582.60K | -3.45M |
| Capital Expenditure | -11.40K | -11.20K | -800.00 | -800.00 | -2.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.40K | -11.20K | -800.00 | -800.00 | -2.20K |
| Total Debt Issued | 1.50M | 1.50M | -- | -- | -- |
| Total Debt Repaid | -15.60K | -15.60K | -14.70K | -14.70K | -24.70K |
| Issuance of Common Stock | 0.00 | 0.00 | 6.12M | 6.12M | 4.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -264.90K | -264.90K | -305.20K |
| Cash from Financing | 950.90K | 931.20K | 3.81M | 3.91M | 2.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.04M | -2.00M | 4.37M | 4.49M | -666.10K |